國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 913778      Online Users : 1209
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    Papers [0/1]
    Patents [0/11]
    Periodical Articles [193/194]
    Conference Papers/Meeting Abstract [41/48]

    Community Statistics


    Item counts issued in 3 years:0(0.00%)
    Items With Fulltext:234(92.13%)

    Download counts of the item
    Download times greater than 0:234(100.00%)
    Download times greater than 100:234(100.00%)
    Total Bitstream Download Counts:146969(2.74%)

    Last Update: 2024-12-01 08:24

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 1-10 of 254. (26 Page(s) Totally)
    1 2 3 4 5 6 7 8 9 10 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2021-12-14 A novel NRF2/ARE inhibitor gossypol induces cytotoxicity and sensitizes chemotherapy responses in chemo-refractory cancer cells Journal of Food and Drug Analysis. 2021 Dec 14;29(4):638-652.
    2021-11-16 Identification of prognostic biomarkers originating from the tumor stroma of betel quid-associated oral cancer tissues Frontiers in Oncology. 2021 Nov 16;11:Article number 769665.
    2021-04 Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors Oncologist. 2021 Apr;26(4):e567-e579.
    2021-03-11 c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation Theranostics. 2021 Mar 11;11(11):5232-5247.
    2021-03-04 Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy Theranostics. 2021 Mar 4;11(10):4672-4687.
    2021-01-12 Ephrin A4-ephrin receptor A10 signaling promotes cell migration and spheroid formation by upregulating NANOG expression in oral squamous cell carcinoma cells Scientific Reports. 2021 Jan 12;11:Article number 644.
    2020-08 The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells Toxicology and Applied Pharmacology. 2020 Aug;401:Article number 115080.
    2020-07-17 Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer[Erratum:Scientific Reports. 2019 Mar;9:Article number 3931.] Scientific Reports. 2020 Jul 17;10:Article number 12216.
    2020-06-28 Index of cancer-associated fibroblasts is superior to the epithelial–mesenchymal transition score in prognosis prediction Cancers. 2020 Jun 28;12(7):Article number 1718.
    2020-06 Pharmacological inhibition of cathepsin S suppresses abdominal aortic aneurysm in mice European Journal of Vascular and Endovascular Surgery. 2020 Jun;59(6):990-999.

    Showing items 1-10 of 254. (26 Page(s) Totally)
    1 2 3 4 5 6 7 8 9 10 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback